Cardiovascular Pathology
Volume 19, Issue 4 , Pages 228-235 , July 2010

High prevalence of amyloid in 150 surgically removed heart valves—a comparison of histological and clinical data reveals a correlation to atheroinflammatory conditions

  • Arnt V. Kristen

      Affiliations

    • Department of Cardiology, Angiology, and Respiratory Medicine, University Hospital Heidelberg, Im Neuenheimer Feld, D-69120 Heidelberg, Germany
    • Corresponding Author InformationCorresponding author. Department of Cardiology, Angiology, and Respiratory Medicine, University Hospital Heidelberg, Im Neuenheimer Feld 410, D-69120 Heidelberg, Germany. Tel.: +49 6221 568611; fax: +49 6221 564105.
    • ,
  • Philipp A. Schnabel

      Affiliations

    • Department of Pathology, University Hospital Heidelberg, Im Neuenheimer Feld, D-69120 Heidelberg, Germany
    • ,
  • Bettina Winter

      Affiliations

    • Department of Cardiology, Angiology, and Respiratory Medicine, University Hospital Heidelberg, Im Neuenheimer Feld, D-69120 Heidelberg, Germany
    • ,
  • Burkhard M. Helmke

      Affiliations

    • Department of Pathology, University Hospital Heidelberg, Im Neuenheimer Feld, D-69120 Heidelberg, Germany
    • ,
  • Thomas Longerich

      Affiliations

    • Department of Pathology, University Hospital Heidelberg, Im Neuenheimer Feld, D-69120 Heidelberg, Germany
    • ,
  • Stefan Hardt

      Affiliations

    • Department of Cardiology, Angiology, and Respiratory Medicine, University Hospital Heidelberg, Im Neuenheimer Feld, D-69120 Heidelberg, Germany
    • ,
  • Achim Koch

      Affiliations

    • Department of Cardiac Surgery, University Hospital Heidelberg, Im Neuenheimer Feld, D-69120 Heidelberg, Germany
    • ,
  • Falk-Udo Sack

      Affiliations

    • Department of Cardiac Surgery, University Hospital Heidelberg, Im Neuenheimer Feld, D-69120 Heidelberg, Germany
    • ,
  • Hugo A. Katus

      Affiliations

    • Department of Cardiology, Angiology, and Respiratory Medicine, University Hospital Heidelberg, Im Neuenheimer Feld, D-69120 Heidelberg, Germany
    • ,
  • Reinhold P. Linke

      Affiliations

    • Reference Center of Amyloid Diseases, amYmed, Am Klopferspitz 19, D-82152 Martinsried, Germany
    • These authors contributed equally to this work.
    • ,
  • Thomas J. Dengler

      Affiliations

    • Department of Cardiology, Angiology, and Respiratory Medicine, University Hospital Heidelberg, Im Neuenheimer Feld, D-69120 Heidelberg, Germany
    • These authors contributed equally to this work.

Received 1 August 2008 ,Revised 3 April 2009 ,Accepted 14 April 2009.

References 

  1. Merlini G, Westermark P. The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies. J Intern Med. 2004;255:159–178
  2. Siqueira Filho AG, Cunha CL, Tajik AJ, et al. M-mode and two-dimensional echocardiographic features in cardiac amyloidosis. Circulation. 1981;63:188–196
  3. Cacoub P, Axler O, De Zuttere D, et al. Amyloidosis and cardiac involvement. Ann Med Interne. 2000;151:611–617
  4. Ladefoged C, Rohr N. Amyloid deposits in aortic and mitral valves. A clinicopathological investigation of material from 100 consecutive heart valve operations. Virchows Arch A Pathol Anat Histopathol. 1984;404:301–312
  5. Falk E, Ladefoged C, Christensen HE. Amyloid deposits in calcified aortic valves. Acta Pathol Microbiol Scand [A]. 1981;89:23–26
  6. Goffin Y. Microscopic amyloid deposits in the heart valves: a common local complication of chronic damage and scarring. J Clin Pathol. 1980;33:262–268
  7. Declaration of Helsinki . Recommendations guiding doctors in clinical research. Adopted by the World Medical Association in 1964. Wiss Med J. 1967;66:25–26
  8. Romeis B, Böck P. Romeis—mikroskopische Technik. 17th ed.. München, Germany: Urban&Fischer; 2001;
  9. Puchtler H, Sweet F, Levine M. On the binding of Congo red by amyloid. J Histochem. 1962;10:355–364
  10. Linke RP. Highly sensitive diagnosis of amyloid and various amyloid syndromes using Congo red fluorescence. Virchows Arch. 2000;436:439–448
  11. Linke RP. Congo red staining of amyloid. Improvements and practical guide for a more precise diagnosis of amyloid and the different amyloidoses. In:  Uversky VN,  Fink AL editor. Protein misfolding, aggregation and conformational diseases. New York: Springer; 2006;p. 239–276
  12. Linke RP, Oos R, Wiegel NM, Nathrath WB. Classification of amyloidosis: misdiagnosing by way of incomplete immunohistochemistry and how to prevent it. Acta Histochem. 2006;
  13. Linke RP. Classification of various amyloid diseases using validated antibodies and Congo red fluorescence. Immunohistochemical typing of 662 patients. Submitted 2009.
  14. Cooper JH. Localized dystrophic amyloidosis of heart valves. Hum Pathol. 1983;14:649–653
  15. Iwata T, Nakamura H, Nagasawa T, et al. Amyloid deposits in heart valves. Acta Pathol Jpn. 1982;32:23–29
  16. Yokota T, Okabayashi H, Ishihara T, et al. Immunohistochemical and pathological characteristics of dystrophic amyloid in surgically excised cardiac valves. Pathol Int. 1994;44:182–185
  17. Smith TJ, Kyle RA, Lie JT. Clinical significance of histopathologic patterns of cardiac amyloidosis. Mayo Clin Proc. 1984;59:547–555
  18. Wright JR, Calkins E. Clinical–pathologic differentiation of common amyloid syndromes. Medicine (Baltimore). 1981;60:429–448
  19. Rocken C, Tautenhahn J, Buhling F, et al. Prevalence and pathology of amyloid in atherosclerotic arteries. Arterioscler Thromb Vasc Biol. 2006;26:676–677
  20. Howlett GJ, Moore KJ. Untangling the role of amyloid in atherosclerosis. Curr Opin Lipidol. 2006;17:541–547
  21. Helske S, Kupari M, Lindstedt KA, Kovanen PT. Aortic valve stenosis: an active atheroinflammatory process. Curr Opin Lipidol. 2007;18:483–491
  22. Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999;340:115–126
  23. Parolari A, Loardi C, Mussoni L, et al. Nonrheumatic calcific aortic stenosis: an overview from basic science to pharmacological prevention. Eur J Cardiovasc Surg. 2009;
  24. Sorrentino G, Bonavita V. Neurodegeneration and Alzheimer's disease: the lesson from tauopathies. Neurol Sci. 2007;28:63–71
  25. Hamaguchi T, Ono K, Yamada M. Anti-amyloidogenic therapies: strategies for prevention and treatment of Alzheimer's disease. Cell Mol Life Sci. 2006;63:1538–1552
  26. Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med. 2005;352:2389–2397
  27. Yilmaz MB. Statins and aortic stenosis in the context of ratio of low- to high-density lipoprotein cholesterol. J Am Coll Cardiol. 2007;50:289–290
  28. Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intensive lipid-lowering in calcific aortic stenosis. N Engl J Med. 2005;352:2389–2397
  29. Moura LM, Ramos SF, Zamorano JL, et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol. 2007;49:554–661
  30. Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003;349:583–596
  31. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29:630–634

PII: S1054-8807(09)00035-0

doi: 10.1016/j.carpath.2009.04.005

Cardiovascular Pathology
Volume 19, Issue 4 , Pages 228-235 , July 2010

Article Tools

* Image Usage & Resolution